Washington [US] August 13 (ANI/FENA): US drug regulators say transplant recipients and others with severely weakened immune systems may receive an extra dose of Pfizer or Moderna to better protect them as the delta variant of the coronavirus continues to spread.
Washington [US], August 13 (ANI/Sputnik): The US Food and Drug Administration (FDA) has authorized the emergency use of the third dose of both Moderna and Pfizer vaccines against COVID-19 for immunocompromised people.
Moscow [Russia] August 5 (ANI): The Russian Direct Investment Fund on Wednesday announced that combination of the first component of Sputnik V vaccine with vaccines by AstraZeneca, Sinopharm, and Moderna demonstrated favorable results.
New Delhi [India], August 3 (ANI): Discussions and negotiations are still not over between the government and US-based COVID-19 vaccine manufacturers for procuring their vaccine, said Dr NK Arora, Chief of National Immunization Technical Advisory Group (NTAGI) on Monday.
New Delhi [India], July 23 (ANI): With various mutations of the SARS-CoV-2 emerging in the near future, there might be a need for the country to adopt a booster dose with second-generation COVID-19 vaccines, said All India Institute of Medical Sciences (AIIMS) chief Dr Randeep Guleria.
New Delhi [India], July 19 (ANI): The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.
Seoul [South Korea], July 16 (ANI/Global Economic): The Korean government announced that it has secured 21.5 million doses of COVID-19 vaccines and is going to supply 35 million doses of vaccine from Friday (July 16) to the end of August.
New Delhi [India], July 12 (ANI): As many as 5,00,000 doses of the Moderna COVID-19 vaccine gifted from the United States arrived at Paro International Airport in Bhutan on Monday.
New Delhi [India], July 9 (ANI): The Government of India is holding discussions with COVID-19 vaccine manufacturers Moderna and Pfizer over several issues including indemnity waiver, said Dr V K Paul, Member (Health), NITI Aayog on Friday.
New Delhi [India], July 8 (ANI): Even as the US giant drug maker Moderna's COVID-19 messenger RNA (mRNA) vaccine is expected to reach India this week, discussions are still going on over indemnity waiver, informed sources.